Cargando…
How promising are HIV-1-based virus-like particles for medical applications
New approaches aimed at identifying patient-specific drug targets and addressing unmet clinical needs in the framework of precision medicine are a strong motivation for researchers worldwide. As scientists learn more about proteins that drive known diseases, they are better able to design promising...
Autores principales: | Martins, Sofia A., Santos, Joana, Silva, Rúben D. M., Rosa, Cátia, Cabo Verde, Sandra, Correia, João D. G., Melo, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585283/ https://www.ncbi.nlm.nih.gov/pubmed/36275021 http://dx.doi.org/10.3389/fcimb.2022.997875 |
Ejemplares similares
-
Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022) -
Integrated in Silico and Experimental Approach towards the Design of a Novel Recombinant Protein Containing an Anti-HER2 scFv
por: Santos, Joana, et al.
Publicado: (2021) -
Discovery of Benzopyrrolizidines as Promising Antigiardiasic Agents
por: Auriostigue-Bautista, Juan Carlos, et al.
Publicado: (2022) -
In the Search of Potential Serodiagnostic Proteins to Discriminate Between Acute and Chronic Q Fever in Humans. Some Promising Outcomes
por: Psaroulaki, Anna, et al.
Publicado: (2020) -
Perils and Promises of Pathogenic Protozoan Extracellular Vesicles
por: Olajide, Joshua Seun, et al.
Publicado: (2020)